ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renkema, T.
Right arrow Articles by Kauffman, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renkema, T.
Right arrow Articles by Kauffman, H.
Eur Respir J 1993; 6: 90-95
Copyright © ERS Journals Ltd 1993


Clinical Trial

Influence of in vivo prednisolone on increased in vitro O2- generation by neutrophils in emphysema

TE Renkema, DS Postma, JA Noordhoek, HJ Sluiter, and HF Kauffman

Evidence is accumulating that neutrophil-derived oxidants substantially contribute to the development of emphysema, especially in smoking individuals. It is not clear, however, why not all smokers develop emphysema. We tested the hypothesis that an abnormality in the oxidative metabolism of polymorphonuclear leucocytes (PMNs) might contribute to the development of emphysema. We investigated in vitro O2- production by peripheral PMNs in patients with stable emphysema and in healthy controls. In addition, we investigated whether in vivo prednisolone may modulate in vitro O2- production by PMNs in patients with emphysema during a stable phase of the disease. Spontaneous O2- production by PMNs was not significantly different in patients and controls. After stimulation with submaximal concentrations of calcium ionophore A23187 and phorbol myristate acetate, however, PMNs from patients with stable emphysema produced more O2- than those from healthy controls, especially in smoking subjects. Moreover, in vitro O2- generation by PMNs significantly decreased after in vivo prednisolone treatment in patients with emphysema. We suggest that our findings reflect an abnormality of PMNs, acting as one of the factors that contribute to the development of emphysema. This abnormality may, at least partially, be dampened by in vivo prednisolone treatment. These findings may provide new insights into the pathogenesis and treatment of pulmonary emphysema. Further studies on pulmonary PMNs are necessary to extend our findings.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. E. REPINE, A. BAST, I. LANKHORST, and The Oxidative Stress Study Gro
Oxidative Stress in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 341 - 357.
[Full Text]


Home page
CROBMHome page
S. E. Barbour, K. Nakashima, J.-B. Zhang, S. Tangada, C.-L. Hahn, H. A. Schenkein, and J. G. Tew
Tobacco and Smoking: Environmental Factors That Modify the Host Response (Immune System) and Have an Impact On Periodontal Health
Critical Reviews in Oral Biology & Medicine, January 1, 1997; 8(4): 437 - 460.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the European Respiratory Society.